References
- Abargel A, Avinoach I, Kravtsov V, et al (2004). Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma. Int J Gynecological Cancer, 14, 354-9. https://doi.org/10.1111/j.1048-891x.2004.014221.x
- Alkushi A, Irving J, Hsu F, et al (2003). Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Archiv, 442, 271-7.
- Arber DA, Tamayo R, Weiss LM (1998). Paraffin section detection of the c-< i> kit gene product (CD 117) in human tissues: Value in the diagnosis of mast cell disorders. Human pathol, 29, 498-504. https://doi.org/10.1016/S0046-8177(98)90066-1
- Boissan M, Feger F, Guillosson JJ, et al (2000). c-Kit and c-kit mutations in mastocytosis and other hematological diseases. J Leukocyte Biol, 67, 135-48. https://doi.org/10.1002/jlb.67.2.135
- Castellsague X, Diaz M, De Sanjose S, et al (2006). Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J National Cancer Inst, 98, 303-15. https://doi.org/10.1093/jnci/djj067
- Catasus L, Gallardo A, Cuatrecasas M, et al (2009). Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis. Modern Pathol, 22, 522-9. https://doi.org/10.1038/modpathol.2009.5
- Jiang X-F, Tang Q-L, Zou Y, et al (2014). Does HBV infection increase risk of endometrial carcinoma? Asian Pac J Cancer Prev, 15, 713-6. https://doi.org/10.7314/APJCP.2014.15.2.713
- Kafshdooz T, Tabrizi AD, Ardabili SMM, et al (2014). Polymorphism of p53 Gene Codon 72 in Endometrial Cancer: Correlation with Tumor Grade and Histological Type. Asian Pac J Cancer Prev, 15, 9603-6. https://doi.org/10.7314/APJCP.2014.15.22.9603
- Karlsson S, Olsson B, Klinga-Levan K (2009). Gene expression profiling predicts a three-gene expression signature of endometrial adenocarcinoma in a rat model. Cancer Cell Int, 9, 12. https://doi.org/10.1186/1475-2867-9-12
- Lammie A, Drobnjak M, Gerald W, et al (1994). Expression of c-kit and kit ligand proteins in normal human tissues. J of Histochem Cytochem, 42, 1417-25. https://doi.org/10.1177/42.11.7523489
- Leath 3rd CA, Straughn Jr JM, Conner MG, et al (2004). Immunohistochemical evaluation of the c-kit protooncogene in sarcomas of the uterus: a case series. J Reproduct Med, 49, 71-5.
- Lee E-J, Kim T-J, Kim DS, et al (2010). p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review. Gynecol oncol, 116, 533-8. https://doi.org/10.1016/j.ygyno.2009.11.018
- Liu F-S (2007). Molecular carcinogenesis of endometrial cancer. Taiwanese J Obstet Gynecol, 46, 26-32. https://doi.org/10.1016/S1028-4559(08)60102-3
- Lux ML, Rubin BP, Biase TL, et al (2000). KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol, 156, 791-5. https://doi.org/10.1016/S0002-9440(10)64946-2
- Meyts ERD, Skakkebkk NE (1994). Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl, 17, 85-92. https://doi.org/10.1111/j.1365-2605.1994.tb01225.x
- Miettinen M, Sobin LH, Sarlomo-Rikala M (2000). Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Modern Pathol, 13, 1134-42. https://doi.org/10.1038/modpathol.3880210
- Naik VR, Hasnan J (2008). C-kit proto-oncogene expression in uterine leiomyosarcomas: case series. Int Med J, 7, 51-4.
- Niwa Y, Hirose K, Matsuo K, et al (2005). Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and< i> p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer letters, 219, 183-90. https://doi.org/10.1016/j.canlet.2004.10.018
- Rubin BP, Singer S, Tsao C, et al (2001). KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res, 61, 8118-21.
- Sakuma Y, Sakurai S, Oguni S, et al (2003). Alterations of the c-kit gene in testicular germ cell tumors. Cancer science, 94, 486-91. https://doi.org/10.1111/j.1349-7006.2003.tb01470.x
- Sakurai S, Fukasawa T, Chong JM, et al (1999). C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of cajal). Cancer Science, 90, 1321-8.
- Scobie JV, Acs G, Bandera CA, et al (2003). C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance. Int J Gynecol Pathol, 22, 149-55. https://doi.org/10.1097/00004347-200304000-00006
- Sever M, Jones TD, Roth LM, et al (2005). Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications. Modern Pathol, 18, 1411-6. https://doi.org/10.1038/modpathol.3800463
- Thanapprapasr D, Thanapprapasr K (2013). Molecular therapy as a future strategy in endometrial cancer. Asian Pac J Prev, 14, 3419-23. https://doi.org/10.7314/APJCP.2013.14.6.3419
- Tsuura Y, Hiraki H, Watanabe K, et al (1994). Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Archiv, 424, 135-41.
- Went PT, Dirnhofer S, Bundi M, et al (2004). Prevalence of KIT expression in human tumors. J Clin Oncol, 22, 4514-22. https://doi.org/10.1200/JCO.2004.10.125
- Winter Iii WE, Seidman JD, Krivak TC, et al (2003). Clinicopathological analysis of< i> c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus. Gynecol Oncol, 91, 3-8. https://doi.org/10.1016/j.ygyno.2003.06.001
Cited by
- Distinct expression profile of lncRNA in endometrial carcinoma vol.36, pp.6, 2016, https://doi.org/10.3892/or.2016.5173